DYNC1LI1 and breast carcinoma: Although not previously reported in DIPG to our knowledge, altered expression of DYNC1LI1 has been described in other malignancies (colorectal cancer and breast cancer in adults), with potential impact on therapy sensitivity [5, 12, 34].